Kopran Ltd announced that the USFDA has completed a surveillance inspection at the API facility of its wholly owned subsidiary, Kopran Research Laboratories Limited, located in Mahad, Maharashtra.
The inspection was conducted from April 21, 2025, to April 25, 2025, and concluded successfully without any observations.